JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025

Stock Price vs Company Growth
1d
0.0%
1w
12.4%
1m
10.0%
3m
13.0%
6m
12.2%
all
22.9%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 10.4 0%
8.7
10.4
Company Overview

Sales
131 Cr
Growth: 9.6%
Profit after Tax
6.4 Cr
Growth: 32.7%
Micro Cap
34.5 Cr
P/E: 5.4x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 131
Growth 9.6%
EBITDA 8.9%
P/S 0.3x
Dividend 0.0%
P/E 5.4x
Book Value ₹ 13.9
PEG Ratio 0.6x
ROE 14.8%
P/B 0.8x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)